Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05943964 · ClinicalTrials.gov registry record · NA
Virtual Rehabilitation in HCT
A NA study of Hematopoietic Cell Transplant, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05943964: Recruiting NA study of Hematopoietic Cell Transplant, sponsored by Emory University.
NCT05943964 is a NA study of Hematopoietic Cell Transplant that is actively recruiting participants, run by Emory University. The registered enrollment target is 40 participants, below the 383-participant average among 6 other Hematopoietic Cell Transplant trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05943964, a NA study of Hematopoietic Cell Transplant, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic GVHD (cGVHD) is a major cause of illness in patients who undergo hematopoietic transplantation (HCT). GVHD can affect any organ in the body, can require several years of treatment, and can impact the quality of life (QoL). Physical activity and exercise have been shown to enhance fitness and improve QoL in chronic illnesses including GVHD, however, patients often have barriers to attending sessions including distance, risk of infection, and physical therapists' lack of experience with pediatric patients. The team's goal is to assess whether a virtual rehabilitation program in children post-HCT (including children with chronic GVHD) is feasible and whether its implementation will improve physical functioning and QoL. Patients between the ages of 8 and 23 years who are at least one hundred days post-HCT will be eligible for participation. Patients will have an assessment by a pediatric physical therapist at the time of study entry, at the end of the rehabilitation program, and approximately 3 months later. They will be supplied with some exercise equipment (such as dumbbells and resistance bands). Patients will have twice weekly half-hour one-on-one online sessions with the physical therapist for 12 weeks. Patients will be recruited through the bone marrow transplant clinic.
Primary Outcome
Percentage of sessions completed per participant. A log will be kept to track the sessions completed by participants during the study participation
Conditions Studied
Interventions
- BEHAVIORAL Virtual exercise and rehabilitation program
Study Locations (1)
Georgia
- Children's Healthcare of Atlanta - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-07-31 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT05943964 shows while recruiting
NCT05943964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 383-participant average among 6 other Hematopoietic Cell Transplant trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Hematopoietic Cell Transplant appearing as the primary indexed condition, and to 1 intervention - of which Virtual exercise and rehabilitation program is the first listed.
NCT05943964 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05943964 about?
NCT05943964 is a clinical study titled "Virtual Rehabilitation in HCT". Chronic GVHD (cGVHD) is a major cause of illness in patients who undergo hematopoietic transplantation (HCT). GVHD can affect any organ in the body, can require several years of treatment, and can impact the quality of life (QoL). Physical activity and exercise have been shown to enhance fitness and...
What is the current status of trial NCT05943964?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-07-31. Estimated completion is 2027-08.
What conditions does trial NCT05943964 study?
This clinical trial studies the following conditions: Hematopoietic Cell Transplant.
What interventions are being tested in trial NCT05943964?
The interventions under investigation include: Virtual exercise and rehabilitation program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05943964?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05943964 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cognitive Training Intervention and Attitudes Towards Genetics
RECRUITING · NA
-
The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients
RECRUITING · NA
-
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
RECRUITING · Phase 2
-
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
RECRUITING
-
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
ACTIVE NOT RECRUITING
-
Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI